Preliminary results from an ongoing phase 2a study of RX-3117, an oral nucleoside analogue to treat advanced urothelial cancer (aUC)

被引：3

作者：

Adashek, Jacob

Pal, Sumanta K.

Chung, Vincent M.

Tagawa, Scott T.

Picus, Joel

Babiker, Hani M.

Gupta, Sumati

Wadlow, Raymond Couric

Poore, Julie

Peterson, Christine

Benaim, Ely

机构：

[1] Western Univ Hlth Sci, Los Angeles, CA USA

[2] City Hope Natl Med Ctr, Duarte, CA USA

[3] Sandra & Edward Meyer Canc Ctr, New York, NY USA

[4] Washington Univ, Sch Med, St Louis, MO USA

[5] Univ Arizona, Ctr Canc, Tucson, AZ USA

[6] Univ Utah, Hunstman Canc Inst, Salt Lake City, UT USA

[7] Virginia Canc Specialists, Fairfax, VA USA

[8] Rexahn Pharmaceut Inc, Rockville, MD USA

来源：

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.4543

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4543

引用

页数：1